National and Kapodistrian University of Athens
Έκφραση του μεταγραφικού παράγοντα E2F-1 στο μη μικροκυτταρικό καρκίνο του πνεύμονα
Abstract
dc:descriptionThe progression of the cell cycle in eukaryotic cells is associated with the phase-specific expression of defined sets of genes, such as proto-oncogenes and tumour suppressor genes, while it is now widely accepted that transcription factors are also implicated. The family of E2F transcription factors and particularly E2F-1 participates to cell cycle progression. Numerous upstream stimulatory and inhibitory signals converge to the pRb/E2F pathway, which governs cellular future. The information concerning alterations of E2F-1 transcription factor in primary malignancies is very limited. Several in vitro studies report that E2F-1 can act either as an oncoprotein or as a tumour-suppressor protein. In view of this dichotomy in E2F-1 functions and its critical role in cell-cycle control, we examined in a panel of 87 non-small cell lung carcinomas (NSCLCs), previously analyzed for defects in the pRb-p52-MDM2 network (Laboratory of Histology and Embryology: Gorgoulis et al, Am J Pathol, 1998; 153: 1749-65 and Gorgoulis et al. Mol Med, 2000; 6: 208-237), the following: (i) the status of E2F-1 at the protein, mRNA, and DNA levels; (ii) its relationship with the kinetic parameters and genomic instability of the tumours; (iii) its association with the status of its transcriptional co-activator CBP (Laboratory of Histology and Embryology: Gorgoulis et al. J Pathol, in press); (iv) main cell-cycle regulatory and E2F-1 - interacting molecules pRb, p53 and MDM2; (v) its correlation with K-Ras protein at the transcriptional level; and (v) its impact on patients outcome. The protein levels of E2F-1 and its co-activator CBP were significantly higher in the tumour area than those observed in the corresponding normal epithelium (P<0.001). E2F-1 overexpression was associated with increased E2F-1 mRNA levels in 82% of the cases examined. The latter finding along with the low frequency of E2F-1 gene amplification observed (9%) (Laboratory of Histology and Embryology: Gorgoulis et al. J Pathol, in press), suggests that the main mechanism of E2F-1 protein overexpression in NSCLCs is deregulation at the transcriptional level. Mutational analysis revealed only one sample with a somatic mutation at codon 371 (Glu → Asp) and one carrying a polymorphism and at codon 393 (Gly → Ser). The most important observation was that carcinomas with increased E2F-1 positivity demonstrated a significant raise in their growth indexes (r=0.402, P=0.001) and were associated with adverse prognosis (P=0.033 by Cox regression analysis). The main determinant of the positive association with growth was the parallel increase between E2F-1 staining and proliferation (r=0.746, P<0.001), whereas apoptosis was not influenced by the status of E2F-1. Moreover, correlation with the status of the pRb-p53-MDM2 network showed that the cases with aberrant pRb expression displayed significantly higher E2F-1 indexes (P=0.033), while a similar association was noticed in the group of carcinomas with deregulated the p53-MDM2 feedback loop. Finally, there was a high tendency of association between the presence of K-Ras mutations and increased E2F-1 expression at mRNA levels (P<0.064). In conclusion, our results suggest that E2F-I overexpression may contribute to the development of NSCLCs by promoting proliferation and provide evidence that this role is further enhanced in a genetic background with deregulated the pRb-p53-MDM2 circuitry.
Degree
thesis:*- Grantor dc:publisher
- National and Kapodistrian University of Athens
- Year dc:date
- 2002
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Bouda, Martha
- Μπουντά, Μάρθα
Subjects
dc:subject × 15- Μοριακη βάση του καρκίνου του πνεύμονα
- Καρκίνος πνεύμονα
- Καρκινογόνοι παράγοντες
- Ογκογονίδια
- Αγγειογένεση
- Ογκοκατασταλτικά γονίδια
- Γονίδια κυτταρικών επιδιορθωτικών συστημάτων
- Τελομεράση
- Ανοσολογική επίβλεψη
- Γενετικές αλλοιώσεις
- Μεταγραφικός παράγοντας E2F-1
- Ιατρική και Επιστήμες Υγείας
- Βασική Ιατρική
- Medical and Health Sciences
- Basic Medicine
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/24179